United States · 
Who invested in Symbiome?
Symbiome's investors include True Ventures, LD Capital and Mission BioCapital.
United States · Venture startup
Who invested in Symbiome
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2022, from 1 source
- Latest round
- VentureOct 2022
- Investors
- 3
The rounds
- Oct 2022
Founders and team
From Symbiome's own website and the SEC filings it signed: 1 founder, 4 on the team.
Larry WeissFounder and CSONamed on its 2020 Form D
- Julia DurackVice President of R&D
- Yvette PicenoDirector of Reseach
- Adam KlausnerExecutive Officeri
- Vicki LevineExecutive Officer, Directori
On the board, as filediAdam D'Augelli
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Symbiome
How much has Symbiome raised?
Symbiome has raised 1 round since 2022, none with a disclosed amount.
When did Symbiome last raise?
Symbiome's most recent round was a Venture in Oct 2022.
Who backed Symbiome first?
Symbiome's first round on record, in Oct 2022, was backed by True Ventures, LD Capital and Mission BioCapital.
What stage is Symbiome at?
Symbiome's latest named round is a Venture, in Oct 2022.
Where is Symbiome based?
Symbiome is based in the United States.
Companies like Symbiome
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.